
VERICI DX PLC
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
VRCI | IL
Overview
Corporate Details
- ISIN(s):
- GB00BM8HZD43
- LEI:
- 213800FI5WE4FVQ3G645
- Country:
- United Kingdom
- Address:
- AVON HOUSE, CF64 2EZ CARDIFF
- Website:
- https://www.vericidx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Verici Dx PLC is an immuno-diagnostics development company specializing in the kidney transplant market. The company develops and commercializes a suite of advanced prognostic and diagnostic tests that form a comprehensive kidney transplant platform. Leveraging artificial intelligence-assisted transcriptomic analysis, its technology deciphers RNA signatures to provide data-driven insights into the body's immune response. These tests offer personalized patient and organ response risk assessments to assist clinicians in medical management throughout the transplant process, from pre-transplant evaluation to late-stage monitoring. The core mission is to predict the risk of organ injury, rejection, and graft failure, ultimately improving patient outcomes and overall graft survival. The company also collaborates with biopharmaceutical and data science partners to foster innovation.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for VERICI DX PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-01 11:40 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.2 KB | |
2025-07-31 18:28 |
Major Shareholding Notification
Holding(s) in Company
|
English | 40.6 KB | |
2025-07-31 16:24 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.9 KB | |
2025-07-31 08:00 |
Regulatory News Service
Tutivia™ abstracts for World Transplant Congress
|
English | 15.3 KB | |
2025-07-30 15:32 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | |
2025-07-30 15:26 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.5 KB | |
2025-07-30 08:00 |
Post-Annual General Meeting Information
Result of Annual General Meeting
|
English | 17.8 KB | |
2025-07-29 08:00 |
Share Issue/Capital Change
Result of WRAP Retail Offer
|
English | 27.3 KB | |
2025-07-28 18:19 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.2 KB | |
2025-07-28 17:55 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB | |
2025-07-28 11:23 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.9 KB | |
2025-07-25 18:22 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.8 KB | |
2025-07-25 14:05 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | |
2025-07-25 14:04 |
Major Shareholding Notification
Holding(s) in Company
|
English | 40.6 KB | |
2025-07-22 08:00 |
Share Issue/Capital Change
WRAP Retail Offer for up to £500,000
|
English | 33.2 KB |
Automate Your Workflow. Get a real-time feed of all VERICI DX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for VERICI DX PLC via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |